GlycoMimetics
GLYC
#10327
Rank
HK$78.86 M
Marketcap
HK$1.22
Share price
-5.42%
Change (1 day)
-45.84%
Change (1 year)

Earnings for GlycoMimetics (GLYC)

Earnings in 2025 (TTM): -HK$0.23 Billion

According to GlycoMimetics 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -HK$0.3 Billion a decrease over its 2023 earnings that were of -HK$0.29 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for GlycoMimetics from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$0.23 Billion-22.17%
2024 -HK$0.3 Billion2.65%
2023 -HK$0.29 Billion-20.97%
2022 -HK$0.37 Billion-26.39%
2021 -HK$0.5 Billion24.3%
2020 -HK$0.4 Billion-11.86%
2019 -HK$0.46 Billion19.92%
2018 -HK$0.38 Billion56.93%
2017 -HK$0.24 Billion-3.3%
2016 -HK$0.25 Billion149.11%
2015 -HK$99.41 Million14.81%
2014 -HK$86.58 Million4.87%
2013 -HK$82.57 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
bluebird bio
BLUE
-HK$1.56 Billion 577.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$92.26 B-40,296.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$70.84 B-30,963.51%๐Ÿ‡ซ๐Ÿ‡ท France
Johnson & Johnson
JNJ
HK$252.18 B-109,970.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-HK$0.14 Billion-41.35%๐Ÿ‡บ๐Ÿ‡ธ USA